468 results on '"Melody So"'
Search Results
2. The intestinal microbiota and cellular therapy: implications for impact and mechanisms
3. How I treat refractory CRS and ICANS after CAR T-cell therapy
4. Alloreactive T cells deficient of the short-chain fatty acid receptor GPR109A induce less graft-versus-host disease
5. NADPH oxidase activation regulates apoptotic neutrophil clearance by murine macrophages
6. Posttransplant chimeric antigen receptor therapy
7. An APRIL-based chimeric antigen receptor for dual targeting of BCMA and TACI in multiple myeloma
8. Oncogenetic-Driven Targeted Therapy for Relapsed/Refractory T-Cell Acute Lymphoblastic Leukemia : A French ALL-Target Observatory Report
9. Corruption of dendritic cell antigen presentation during acute GVHD leads to regulatory T-cell failure and chronic GVHD
10. Matriptase activation connects tissue factor–dependent coagulation initiation to epithelial proteolysis and signaling
11. How I Treat Refractory CRS and ICANS Following CAR T-cell Therapy
12. Harnessing ADR T cells to enhance allo-HCT
13. NADPH oxidase controls neutrophilic response to sterile inflammation in mice by regulating the IL-1α/G-CSF axis
14. Tc17 cells are a proinflammatory, plastic lineage of pathogenic CD8+ T cells that induce GVHD without antileukemic effects
15. Lung parenchyma-derived IL-6 promotes IL-17A–dependent acute lung injury after allogeneic stem cell transplantation
16. Analysis of Bendamustine Lymphodepletion, CD19 CART Expansion, Safety and Efficacy in Patients with Rel/Ref Non-Hodgkin Lymphoma
17. Outcomes for Acute Myeloid Leukemia Relapse after Allogeneic Hematopoietic Cell Transplantation Remain Poor in the Modern Era
18. Initial Results of a Phase 1 Study of Daratumumab, Ixazomib, and Dexamethasone in Newly Diagnosed and Previously Treated AL Amyloidosis
19. Microbial Bile Acid Metabolism Shapes Effector T Cell Responses during Inflammation in Mouse and Human
20. The Development of Carhlh after Axicabtagene Ciloleucel Is Associated with Poor Outcomes
21. Higher Rates of Severe Infection and Persistent Cytopenias in Long-Term CAR19 Responders Than after Autologous HCT: A Single Institution Study of 139 Subjects
22. Updated Results of an Investigator-Initiated Phase II Study of Pembrolizumab and Romidepsin for Patients with Relapsed or Refractory T-Cell Lymphoma (TCL) with Survival Analysis
23. Gray platelet syndrome: proinflammatory megakaryocytes and α-granule loss cause myelofibrosis and confer metastasis resistance in mice
24. Harnessing ADR T cells to enhance allo-HCT
25. Analysis of Bendamustine Lymphodepletion, CD19 CART Expansion, Safety and Efficacy in Patients with Rel/Ref Non-Hodgkin Lymphoma
26. CD8+ TEMRA Clones Cause Platelet Lysis in Immune Thrombocytopenia
27. Posttransplant Lymphoproliferative Disorder (PTLD) Following Transplantation at Northwestern University: Choice of Immunosuppressive Agents Does Not Impact Outcomes in PTLD
28. Impact of Extranodal Disease Involvement on Outcomes in Post-Transplant Lymphoproliferative Disorder
29. Updated Results of an Investigator-Initiated Phase II Study of Pembrolizumab and Romidepsin for Patients with Relapsed or Refractory T-Cell Lymphoma (TCL) with Survival Analysis
30. Delayed Neutrophil Engraftment in Autologous Transplant Patients with Very High CD34+ Cell Collections in a Single Apheresis
31. Initial Results of a Phase 1 Study of Daratumumab, Ixazomib, and Dexamethasone in Newly Diagnosed and Previously Treated AL Amyloidosis
32. Microbial Bile Acid Metabolism Shapes Effector T Cell Responses during Inflammation in Mouse and Human
33. The Development of Carhlh after Axicabtagene Ciloleucel Is Associated with Poor Outcomes
34. Allogeneic Hematopoietic Cell Transplantation in Patients with Relapsed or Refractory Acute Leukemia
35. Outcomes for Acute Myeloid Leukemia Relapse after Allogeneic Hematopoietic Cell Transplantation Remain Poor in the Modern Era
36. An efferocytosis-induced, IL-4–dependent macrophage-iNKT cell circuit suppresses sterile inflammation and is defective in murine CGD
37. Immune insufficiency during GVHD is due to defective antigen presentation within dendritic cell subsets
38. Allogeneic Hematopoietic Cell Transplantation in Patients with Relapsed or Refractory Acute Leukemia
39. Impact of Extranodal Disease Involvement on Outcomes in Post-Transplant Lymphoproliferative Disorder
40. Delayed Neutrophil Engraftment in Autologous Transplant Patients with Very High CD34+ Cell Collections in a Single Apheresis
41. Posttransplant Lymphoproliferative Disorder (PTLD) Following Transplantation at Northwestern University: Choice of Immunosuppressive Agents Does Not Impact Outcomes in PTLD
42. KIT signaling regulates MITF expression through miRNAs in normal and malignant mast cell proliferation
43. The Intestinal Microbiota Correlates with Response and Toxicity after CAR T Cell Therapy in Patients with B-Cell Malignancies
44. TIRAP Drives Marrow Failure through an Ifnγ-Hmgb1 Axis That Disrupts the Endothelial Niche
45. Disease Characteristics of Multiple Myeloma Involving BRAF Mutations
46. Characteristics of High-Risk Polycythemia Vera Patients with Suboptimal Response to First-Line Therapy Who Switched to Ruxolitinib Vs Those Who Did Not Switch: Findings from PV-Switch, a Multinational, Retrospective Chart Review Study
47. Highly Selective Irreversible ITK Inhibitor Cpi-818 Reduces Acute Graft-Versus Host Disease
48. Exploration of Language As a Barrier to the Assessment and Management of CAR T-Cell Therapy Associated Toxicities
49. A Prospective, Observational, Multi-Center Study of Rurioctocog Alfa Pegol Pharmacokinetic-Guided Prophylaxis Using Mypkfit in Severe Hemophilia a Patients in Taiwan (ATTRACT-HA Study): An Interim Analysis
50. Analysis of PET-CT Derived Radiomic Biomarkers with Efficacy, Safety, and Expansion of Axicabtagene Ciloleucel (Axi-Cel) in Patients with Relapsed or Refractory Large B-Cell Lymphoma (LBCL)
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.